Cingulate Inc

NASDAQ:CING 3:49:59 PM EDT

0.88

+0.03 (+3.31%)

7:36:08 PM EDT: $0.86 -0.02 (-1.78%)

Cingulate Inc Stock, NASDAQ:CING

1901 West 47th Place, Kansas City, Kansas 66205

United States of America

Phone: +1.913.942.2300

Number of Employees: 13

http://www.cingulate.com

Description

Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.